Implementation strategies to increase the reach and utilization of smoking cessation treatment in cancer patients

Authors: LeLaurin JH, Dallery J, Silver N, Markham MJ, Theis RP, Staras SA, Gurka MJ, Salloum RG

Category: Survivorship & Health Outcomes/Comparative Effectiveness Research
Conference Year: 2020

Abstract Body:
Purpose: An estimated 25% of US cancer survivors smoke. Smoking after a cancer diagnosis increases mortality, risk of recurrence, and negatively impacts treatment effectiveness and quality of life. Although assessment of smoking is common in oncology practice, increased access to and utilization of evidence-based smoking cessation treatment is needed to improve outcomes. Methods: We conducted a pilot assessing the feasibility and preliminary efficacy (7-day smoking abstinence) of implementation strategies to increase cessation treatment use among cancer patients. Implementation strategies included electronic referral using the opt-out approach and presenting patients with the choice of three cessation treatment options. Patients at three oncology clinics were offered the choice of referral to external cessation services (quitline or in-person group sessions) or a 6-week cognitive behavioral therapy intervention (mCBT) delivered via smartphone video conferencing with a tobacco treatment specialist. Patients completed baseline questionnaires and outcomes were collected at 12 weeks. Results: Of 545 eligible patients visiting the 3 clinics, 90 agreed to enroll in the study for a reach of 16.5%. Enrollment rates by clinic ranged from 11.3%-22.9%. Of the enrolled patients, 39 (43.3%) chose quitline, 37 (41.1%) chose mCBT, and 14 (15.6%) chose group sessions. Convenience was the most frequently reported reason for cessation treatment choice in quitline and mCBT patients. Of the patients reached for follow-up (n=35), 19 (54.3%) reported receiving cessation treatment. Using intent-to-treat analysis, 3 (7.7%) quitline, 2 (5.4%) mCBT, and 2 (14.3%) group patients reported 7-day abstinence, for a 7.8% quit rate. Mean treatment acceptability scores were highest for mCBT (8.0), followed by quitline (5.9), and group (5.7). Conclusions: This pilot study demonstrates the feasibility of using implementation strategies to promote access and utilization of cessation treatment among cancer patients. Providing multiple cessation options may increase patient engagement. Tailoring implementation strategies to individual clinic workflows (e.g. timing of discussions, personnel entering referrals) may improve reach. Opportunities remain for improving intervention reach and utilization.

Keywords: tobacco, implementation science